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Abstract: The presence of pharmaceutical products in the water cycle may cause harmful effects such
as morphological, metabolic and sex alterations in aquatic organisms and the selection/development
of organisms resistant to antimicrobial agents. The compounds’ stability and persistent character
hinder their elimination by conventional physico-chemical and biological treatments and thus, the
development of new water purification technologies has drawn great attention from academic and
industrial researchers. Recently, the electro-Fenton process has been demonstrated to be a viable
alternative for the removal of these hazardous, recalcitrant compounds. This process occurs under the
action of a suitable catalyst, with the majority of current scientific research focused on heterogeneous
systems. A significant area of research centres working on the development of an appropriate catalyst
able to overcome the operating limitations associated with the homogeneous process is concerned
with the short service life and difficulty in the separation/recovery of the catalyst from polluted water.
This review highlights a present trend in the use of different materials as electro-Fenton catalysts
for pharmaceutical compound removal from aquatic environments. The main challenges facing
these technologies revolve around the enhancement of performance, stability for long-term use,
life-cycle analysis considerations and cost-effectiveness. Although treatment efficiency has improved
significantly, ongoing research efforts need to deliver economic viability at a larger scale due to the
high operating costs, primarily related to energy consumption.
Keywords: electro-Fenton; heterogeneous catalyst; pharmaceuticals; aqueous solution
1. Introduction
Anthropogenic activities are considered a significant threat to the ecological environ-
ment with unsustainable development practices leading to deterioration in the surface
water resource quality and as such, contamination issues for drinking water supply [1].
Therefore, growing awareness of environmental concerns has prompted the introduction
of new legislation in order to preserve the environment and natural resources. The 2030
Agenda for Sustainable Development Goals, approved by all United Nations Member
States in 2015, includes a specific aim focusing on the provision of safe and clean drinking
water—with the protection of water sources a critical component [2].
More than 700 emerging pollutants and their derivatives have been detected in the Eu-
ropean aquatic environment [3]. These included heavy metals and biological contaminants,
as well as synthetic organic pollutants and emerging pollutants such as pharmaceuticals
(both prescription and over-the-counter drugs), personal care products, flame retardants,
cationic surfactants, life-style products (caffeine and nicotine), industrial additives and
agrochemicals.
The range of pharmaceutical products may be classified into antibiotics, nonsteroidal
anti-inflammatory drugs (NSAIDs), β-blockers, contrast agents, anticonvulsants, hormones
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and lipid regulators [4], with antibiotics and NSAIDs most commonly reported as water
pollutants due to their high use for clinical purposes (Table 1) [5]. The increasing demand
for new drugs has resulted in more than 3000 pharmaceuticals being produced, with new
chemical and biologically active molecules being released into the environment. Pharma-
ceutical products have been detected in many aqueous resources such as surface water,
wastewater and even drinking water at concentrations ranging up to 10 µg/L [4]. The pri-
mary route of entry to the environment is from effluents generated on pharmaceuticals
industries, hospitals and houses (containing both parent compound and metabolites ex-
creted by animals and humans) with a minor contribution from the inappropriate disposal
of expired drugs [6]. In addition, urban runoff and leaching from agricultural land con-
tribute to the flow of drugs into the groundwater streams [7]. Given the potential harmful
effects of these emerging pollutants, European Directives 2015/495/EU and 2018/840/EU
include antibiotics such as amoxicillin and ciprofloxacin requiring testing to monitor their
occurrence, distribution, frequency and inclusion in risk assessment.
The main methods widely used for the removal of pharmaceutical products in conven-
tional sewage treatment plants include biotransformation/biodegradation and/or adsorp-
tion on classical adsorbents (e.g., activated carbon) [9]. Previous studies have considered
wastewater treatment plants (WWTPs) as the main gateways for the release of emerging
pollutants into aquatic environments, e.g., Carballa et al. [10] reported around 70% ibupro-
fen removal by conventional biological treatments in municipal WWTPs, however, classical
WWTPs are not specifically designed to remove recalcitrant, low level pharmaceuticals.
Advanced oxidation processes (AOPs) have been considered as a suitable range
of technologies to reduce concentration levels and toxicity associated with the pharma
compound—where they are able to deal with the complex stable structures. In particu-
lar, electrochemical advanced oxidation processes such as the electro-Fenton process are
regarded as an eco-friendly approach based on the formation of strong oxidants with
potential to degrade and mineralise organic pollutants.
In the electro-Fenton process, the in situ electrogeneration of hydrogen peroxide under
acidic pH via oxygen reduction (Equation (1)), minimises the operating costs through
the avoidance of the continuous addition of hydrogen peroxide to the bulk solution (as
is common in the standard Fenton process). The generated hydrogen peroxide reacts
with ferrous ion resulting in the production of hydroxyl radicals and ferric ions through
Fenton’s reaction (Equation (2)). Simultaneously, the continuous regeneration of ferrous
ions from ferric ions occurs on the cathode (Equation (3)) ensuring an adequate catalytic
concentration in the aqueous phase, with the associated reduction in free radical scavenging
(Equation (4)):
O2 + 2H+ + 2e− → H2O2 (1)
Fe2+ + H2O2 + H+ → Fe3+ + H2O + •OH (2)
Fe3+ + e− → Fe2+ (3)
Fe2+ + •OH→ Fe3+ + OH− (4)
Furthermore, water molecules in the bulk solution may be oxidised to oxygen at the an-
ode subsequently generating additional hydrogen peroxide (via Equation (5)). By using an-
ode materials with high over potential such as platinum and boron-doped diamond (BDD),




O2 + 2H+ + 2e− (5)
H2O→ •OH + H+ + e− (6)
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Table 1. List of common pharmaceuticals mineralised by electro-Fenton processes.
Pharmaceutical. Class Group WS (mg/mL) PNEC
a
(g/L) Pharmaceutical Class Group WS (mg/mL)
PNEC a
(µg/L)
Acebutolol β-blocker Cardioselective 0.259 n.a. Amoxicillin Antibiotic Penicillin 3.43 489.53
Atenolol β-blocker Cardioselective 13.3 n.a. Cephalexin Antibiotic Cephalosporin 10 228.73
Cephazolin Antibiotic Cephalosporin 0.21 2432.48 Ciprofloxacin Antibiotic Fluoroquinone 30 77.02
Chloramphenicol Antibiotic Chloramphenicol 2.5 186.59 Diclofenac NSAIDs Acid aceticderivatives 0.002 11.32
Enoxacin Antibiotic Fluoroquinone 3.43 94.93 Gemfibrozil NSAIDs Fibric acidderivatives 0.011 223.09
Gentamycin Antibiotic Aminoglycosides 100 n.a. Ibuprofen NSAIDs Propionic acidderivatives 0.021 25.43
Levofloxacin Antibiotic Fluoroquinone 40.4 57.10 Metronidazole Antibiotic Nitroimidazole 5.92 13.00
Nafcillin Antibiotic Penicillin 0.017 n.a. Naproxen NSAIDs Propionic acidderivatives 0.015 10.36
Ofloxacin Antibiotic Fluoroquinone 25 57.10 Propranolol β-blocker Cardioselective 0.061 13.01
Sulfamethazine Antibiotic Sulfonamides 1.5 n.a. Sulfamethizole Antibiotic Sulfonamides 0.10 n.a.
Sulfamethoxazole Antibiotic Sulfonamides 0.61 164.58 Tetracycline Antibiotic Tetracyclines 3.87 460.38
NSAIDs: nonsteroidal anti-inflammatory drugs, WS: water solubility (values obtained from PubChem®database), PNEC: predicted no-effect concentrations using Daphnia Magna model (µg/L). a [8].
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According to the literature, the electro-Fenton mechanism depends considerably on
the solution pH [12]. Under acidic conditions (pH < 4.5), the limiting step in the electro-
Fenton process corresponds to the iron redox cycle, determined by the solubility of the
catalyst. H2O2 activation by the dissolved iron source at neutral and alkaline conditions
is negligible and thus, maintaining a soluble catalyst determines the production rate of
hydroxyl radicals.
Despite research demonstrating high removal and mineralisation percentages with a
wide range of pharmaceutical target pollutants, the electro-Fenton process suffers from mul-
tiple operational limitations, mainly attributed to the homogeneous process. These include
a narrow working pH, difficult catalyst reusability and additional pollution by soluble salts
in the effluent.
To advance the field and develop industrially scalable technology, the search of
new heterogeneous catalysts applied to electro-Fenton processes has gained attention
from the scientific research community with a considerable number of Scopus®indexed
scientific publications over recent years. The number of relevant articles, reviews, report,
data studies and books including the keyword “heterogeneous catalyst” related to water
purification using electro-Fenton process has increased exponentially over the past 5 years
(Figure 1a), with research on antibiotic removal gaining more interest than the other classes
of pharmaceutical compounds (Figure 1b).
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The research reported in this review article specifically covers this period of intense
growth (2016–2020), focusing on phar aceutical re oval by heterogeneous electro-Fenton
process. The basic fundamentals and characteristics of heterogeneous electro-Fento pro-
cess have b en described to aid in the understand of the key rol play d by reactive oxygen
species roduced by the proc ss. Furthermore, an analysis of critical process parame-
ters underpinning heterogeneous catalysts for pharm ceutical removal has been d tail d.
Finally, the case study example is included, tailing the application of heterog neous
lectro-Fenton process for the removal of common pharmaceutic ls from aqueous solution.
2. Fundamentals of Heterogeneous Electro-Fenton Process
To date, the Hab r–Weiss cycle mechanism has been considered the primary reaction
mechanism for heterogeneous electro-Fenton process [12]. Hydroxyl radical generation on
the catalyst surface begins by the interaction of H2O2 and iron species such as ≡ FeIII-OH
and ≡ FeII-OH (Equation (7)) resulting in a ≡ FeIII-OH(H2O2)(s) formation (Equation (8))
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at the cathode. This complex may be subjected to reversible ground-state electron trans-
fer (Equation (9)) and further deactivation (Equation (10)) to generate ≡ FeII-OH and
HO2•. Subsequently, ≡ FeII-OH catalyses H2O2 decomposition to form hydroxyl radi-
cals (Equation (11)) which subsequently attack pollutant species, theoretically resulting
in the complete mineralisation of the parent compound and intermediates to CO2 and
H2O [12,13]:
≡ FeIII-OH + e− →≡ FeII-OH (7)
≡ FeIII-OH + H2O2 →≡ FeIII-OH(H2O2)(s) (8)
≡ FeIII-OH(H2O2)(s) →≡ FeII-OH(HO2•)(s) + H+ (9)
≡ FeII-OH(HO2•)(s) →≡ FeII-OH + HO2• + H+ (10)
≡ FeII-OH + H2O2 →≡ FeIII-OH + •OH + OH− (11)
Nowadays, metal sulphides (MoS2, WS2, Cr2S3, CoS2, PbS or ZnS) are widely used as
excellent co-catalysts to enhance hydroxyl radical production. The unsaturated sulphur
atoms on the metal sulphides surface can capture protons to generate H2S and release
metallic active sites with reductive properties. Thus, co-catalysts facilitate the continuous
production of ≡ FeII-OH and hydroxyl radical generation (Equations (12)–(17)) [14]:
≡ CoII-OH + ≡ FeIII-OH→≡ CoIII-OH + ≡ FeII-OH (12)
≡ CuI-OH + ≡ FeIII-OH→≡ CuII-OH + ≡ FeII-OH (13)
≡MoIV-OH + ≡ FeIII-OH→≡MoVI-OH + ≡ FeII-OH (14)
≡ CoII-OH + H2O2 →≡ CoIII-OH + + •OH + OH− (15)
≡ CuI-OH + H2O2 →≡ CuII-OH + + •OH + OH− (16)
≡MoVI-OH + H2O2 →≡MoIV-OH + + •OH + OH− (17)
3. Experimental Variables and Parameters of Heterogeneous Electro-Fenton Process
The performance of the electro-Fenton process depends on the several experimental
variables such as cell configuration, electrodes material, solution pH, air flow (oxygen
supply), and both catalyst and pollutant concentrations. Of these experimental variables,
catalyst concentration, applied current density and pH have received the most attention
with optimisation reaching maximum efficiency in terms of the chemical oxygen demand
(COD) and total organic carbon (TOC) removal. However, relevant parameters related to
oxidation efficiency and energy consumption must also be analysed to evaluate the electro-
Fenton process performance. To this end, multiple iterative electro-Fenton experimental
runs are often carried out by varying exclusively one influencing variable. In general,
concentration–time profiles are produced, which exhibit exponential decay with increased
treatment with rate constants generated via pseudo-first order kinetics.
3.1. Effect of Catalyst Concentration
The degradation rate classically increases as a function of catalyst loading reaching a
plateau; however, additional catalyst concentration creates the negative effects decreasing
removal efficiency. This is likely due to the presence of scavenging reactions between hydroxyl
radicals and an excess of iron released into the bulk solution (Equations (18) and (19)) [15,16]:
Fe2+ + •OH→ Fe3+ + OH− (18)
•OH + H2O2 → H2O + HO2− (19)
Furthermore, the inclusion of excessive catalyst promotes aggregation within the
bulk solution which results in a decrease in catalyst active surface area and an associated
reduction in degradation [15].
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3.2. Influence of Applied Current Intensity
Applied current intensity has been considered responsible for the regulation of hy-
droxyl radical generation (Equations (1) and (3)), and M(OH) production (Equation (7)) [17].
At low current densities, H2O2 electrogeneration takes place under conditions of con-
trolled electron transfer. Therefore, increasing the current enhances charge distribution
through the cathode, leading to an increase in hydroxyl radical concentration within the
solution. Nevertheless, the excessive current can promote side reactions such as H2O2
decomposition (Equation (20)) and a reduction of as-generated protons to hydrogen gas
(Equation (21)) [15,18]:
H2O2 + 2 H+ + 2 e− → 2 H2O, E0 = 1.77 V vs. SHE (20)
2 H+ + 2 e− → 2 H2, E0 = 0 V (21)
3.3. Solution pH Effect
pH of the solution represents a key role in the degradation and subsequent mineral-
isation of organic pollutants via heterogenous electro-Fenton process in the presence of
solid catalysts [19], primarily due to catalyst surface charge and dissolution characteris-
tics. The use of a heterogeneous catalyst allows operation at circumneutral and alkaline
conditions with slow degradation efficiency noted over pH 4.5 as a result of the H2O2
decomposition into H2O and O2 [16]. pH variations have been associated with the contin-
uous hydrolysis of catalyst ions such as iron and copper, leading to enhanced pollutant
removal mediated by free radicals oxidation [20].
3.4. Oxidation Efficiency and Energy Consumption
From total organic carbon (TOC) measurements, mineralisation current efficiency
(MCE) for an electrolysed solution may be estimated using Equation (22)) [21]:
MCE (%) = (n × F × ∆(TOC)exp)/(4.32 × 107 ×m × I × t) (22)
where n is the number of electrons consumed per molecule mineralised, F is Faraday’s
constant (96,500 C/mol), V is the volume (L), ∆(TOC)exp is the experimental TOC decay
(mg/L), 4.32 × 107 a conversion factor, m is the number of carbon atoms within the
molecule and I is the applied total current (A). The number of electrons (n) exchanged per
each pollutant molecule is estimated as a function of total mineralisation to carbon dioxide
and inorganic ions.
Electrical energy consumption has been considered as the main operational cost for
electrochemical technologies [22,23]. When operating at a constant applied current, the
energy consumption per unit volume (EC) and unit TOC mass (ECTOC) are calculated as
described in Equations (23) and (24), respectively:
EC (kWh/m3) = (Ecell × I × t)/V (23)
ETOC (kWh/gTOC) = (Ecell × I × t)/(∆(TOC)exp × V) (24)
where Ecell is the average potential difference (V), I is the applied current intensity (A), V the
volume (L), t the electrolysis time (h) and ∆(TOC)exp the experimental TOC decay (mg/L).
The potential generation of more toxic organic compounds than the parent pollutant
via the electro-Fenton process represents one of the main drawbacks associated with the use
of this technology. Thus, adequate parameters such as the average oxidation state (AOS) and
carbon oxidation state (COS) are often selected to analyse the proportion of biodegradable
organic compounds present into the aqueous solution. These parameters are derived based
upon TOC and COD evolution and described by Equations (25) and (26) [24,25]:
AOS = 4 × (TOC-COD)/TOC (25)
COS = 4 × (TOC0-COD)/TOC0 (26)
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where TOC0 is the initial concentration of total organic carbon (mmol C/L), TOC the total
organic carbon at time t (mmol C/L) and COD the chemical oxygen demand (mmol O2/L)
at time t. COS represents the carbon oxidation efficiency considering the carbon removed
from the solution as gaseous CO2. Regarding AOS, the maximum value +4 corresponds to
the highest oxidised state of carbon, CO2, with the minimum value −4 corresponding to
the most reduced state of carbon, CH4.
4. Heterogeneous Catalysts
Apart from the experimental variables mentioned above which affect the efficiency
of heterogeneous electro-Fenton process, mass transfer limitations are considered an im-
portant drawback of these catalytic systems [26]. The catalytic reaction takes place after
the diffusion step towards the catalyst particles (external/film diffusion) and through
the pore within the particle (internal diffusion). As a consequence, the search for a novel
heterogeneous catalyst able to reduce the mass transfer limitations represents a challenging
milestone on the research community.
Many publications have demonstrated the potential of natural iron minerals including
hematite, goethite and magnetite, to catalyse H2O2 decomposition to hydroxyl radicals
(Figure 2A) [26,27]. Recently, Barhoumi et al. [27] assessed the viability of pyrite as a
heterogeneous iron source for antibiotic degradation. At optimum conditions, around
96% mineralisation was achieved after 8 h treatment, suggesting pyrite as an adequate
solid catalyst for the electro-Fenton process. The efficiency of the pyrite-based electro-
Fenton process was associated with the self-regulator of iron dosage and pH in the system
according to the Equations (27)–(29):
2 FeS2 + 7 O2 + 2 H2O→ 2 Fe2+ + 4 SO42− + 4 H+ (27)
2 FeS2 + 14 H2O2 → 2 Fe3+ + 14 H2O + 4 SO42− + 2 H+ (28)
FeS2 + 14 Fe3+ + 8 H2O→ 15 Fe2+ + 2 SO42− + 16 H+ (29)
Additionally, the use of chalcopyrite has been evaluated by Droguett et al. (2020)
for cephalexin degradation; this mineral possesses the same catalytic behaviour as pyrite,
again acting as a self-regulator in the bulk solution (Equation (30)):
CuFeS2 + 16 Fe3+ + 8 H2O→ Cu2+ + 17 Fe2+ + 2 SO42− + 16 H+ (30)
Natural iron-based composites have been investigated for heterogeneous electro-
Fenton process targeting removal of pharmaceuticals [28]. Iron nanoparticles have high
reactivity in water, leading to high surface energy, oxidation and passivation processes. To
overcome these drawbacks, transition metals, such as copper, have been incorporated with
iron nanoparticles, resulting in the development of bimetallic nanoparticle composites. The
synergetic effect of the physicochemical properties of each metal enhances both the degrada-
tion activity and stability, providing efficient electron transfer. Campos et al. [29] evaluated
the removal of nafcillin from aqueous solution using iron and copper monometallic and
bimetallic nanoparticles as electro-Fenton catalysts. They used bimetallic nanoparticles as
the catalyst to overcome the limitations associated with the use of ferromagnetic materials.
XRD and SEM characterisation confirmed the presence of metallic Fe, Cu and FeOOH in
addition to a range of morphologies attributed to formation of metal oxides. In line with
the theory, the use of bimetallic nanoparticles catalysed the total removal of the antibi-
otic with lower treatment time than either monometallic nanoparticle. However, during
catalyst reuse trials, the pollutant removal percentage decreased by up to 77% following
three consecutive cycles due to the formation of oxides (FeO, Fe2O3 and CuFe2O4) on the
nanoparticle surface. Similar results were obtained by Ghasemi et al. [15], who synthesised
nano-layered double hydroxide (NLDH) compounds containing copper and iron, who
studied catalytic activity toward gentamicin degradation. Their hydrotalcite structure
promoted high surface area and ion-exchange, exhibiting negligible metal leaching and
almost full antibiotic degradation under optimal conditions.
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Although the classical-Fenton reaction is based on Fe2+/H2O2, other transition metals
such as copper, chromium, cobalt and manganese may promote H2O2 decomposition
into •OH by ‘Fenton-like’ pathways. Copper, as described above, possesses similar redox
beha iour to iron oper ting, under a similar broad pH r nge to the iron system. Given the
importa ce of the role of the structure, sev ral perovskites cont ining c per structures
have been investigat d. LaCu1-xMxO3 (where M = Mn, Ti; 0 ≤ x ≤ 0.8) was prepared
and t sted by Carrasco-Diaz e al. using paracetamol as the hemic l probe under mild
conditions and circu neutral pH [30]. Manganese and titanium were selected as the
B position metals owing to their good ctivity in Fenton-like reactions. Based on their
results, copper ex ibited higher r dox ac ivity, wherea titanium and manganese we e
not responsibl for the enhancement of n ib otic degradation. N gligible metal le ching
and high metal stability within the netw rk structure confirm this material as a pr mising
alternative catalys .
Novel composites containing iron species have been synthesised [31]. Fe2O3-modified
ka lin was proposed b Özcan et l. [31] as a promising alternative for enoxacin degra-
dation fr m aqueous environments. The use of clays such as ka lin and perlite has been
widely applied primarily as catalyst supports due to their low cost, high adsorption ability
and eco-friendly structure [32]. Carbonaceous materials have also been recently used as
immobilisation substrates to enhance catalytic activity, stability and reusability. The in-
corporation of core-shell structured catalysts, with a transition metal nanoparticle core
and a porous carbon shell, allows for enhanced catalytic properties whilst minimising
catalyst agglomeration. Fe/Fe3C@PC core-shell structured materials were synthesised by
Du et al. [33] and tested for the degradation of sulfamethazine solutions. The aid with
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sustainability and catalyst reuse, this catalyst can be magnetically captured and further
recovered via a thermal treatment in a H2 atmosphere. As was expected, Fe/Fe3C@PC
exhibited enhanced performance compared to the pristine iron oxides, given the synergetic
effect between Fe/Fe3C and PC, again demonstrating the potential in nano-engineering to
improve electro-Fenton catalyst form and function.
Graphene and its derivatives have also been considered suitable supporting materials
for catalyst immobilisation due to their high thermal and electrical conductivity, strong
mechanical and chemical stability, extremely high specific area and relatively simple
synthesis methods from graphite (by chemical oxidation–exfoliation–reduction procedures
and mechanical means). The oxygenated functional groups located on the edges (carbonyl
and carboxyl) and basal plane (epoxides and hydroxyl) act as a nucleation site for metal
ions to produce graphene-based nanocomposites [34].
5. Heterogeneous Electro-Fenton Process with Iron Functionalised-Cathode
Further work in the discipline of nano-engineering includes the use of three- di-
mensional electrodes in order to enhance the mass transfer and conductivity into the
electro-Fenton system [35]. This innovative electrochemical system provided an enhanced
effective contact area and numerous micro-electrolysis cells; therefore, the electrochemi-
cal reactions take places on the main electrode surface and the particle electrode surface.
The cathodic-modification via the addition of iron and/or transition metal oxides, incorpo-
rates dual functionality, as both a counter electrode and an iron source, and may be carried
out by the immobilisation of an iron source and/or through the chemical modification of
the carbonaceous material.
Although these systems show high pollutant removal effectiveness, some operational
limitations may hinder their widespread use in water purification, such as low current
efficiency and narrow operating pH range. Mohammadi et al. [35] studied Fe–Ni foam
particles on three-dimensional electrodes for NSAIDs removal using Ti–PbO2 and graphite
felt as the anode and cathode, respectively. This system achieved nearly a two-fold increase
in the removal percentage when compared to a corresponding 2D electro-Fenton system.
The authors attributed the increased rate to a higher concentration of radical species
generation because the Ni-foam electrode may activate molecular oxygen to produce single
oxygen. Recently, Luo et al. [20] proposed a Cu-doped Fe@Fe2O3 core–shell nanoparticle
(CFF) system loaded on a nickel-based foam as the cathode and examined efficiency for
tetracycline degradation. XRD and XPS experiments allowed the determination of the
catalyst composition showing an Fe/Cu nanoparticle core and an external layer-shell of
metal oxides (Fe2O3, Cu2O and CuO). Catalytic performance was reported to decline with
increasing Cu content due to a reduction in active Fe0 sites. For optimal Fe/Cu loadings,
catalyst reusability was demonstrated over six successive runs with negligible iron leaching
was observed.
The development of iron-functionalised cathodic materials (Figure 2B), such as active
carbon/fibre, carbon felt, graphite felt and carbon aerogels, has recently received signifi-
cant attention. In particular, Mi et al. [36] investigated the electrocatalytic performance of
mesoporous MnXCo3-XO4 nanoparticle modified carbon felt as an electro-Fenton cathode.
Higher ciprofloxacin degradation rates were achieved as a result of increasing electron
transfer and the redox reactivity. This was associated with the synergetic effect of embed-
ded cobalt and manganese within the mesoporous matrix and promotion of more accessible
active sites. The reusability of the modified cathode was evaluated via five successive
cycles with minimal ion leaching measured (below 3.5 ppm). Similarly, Yang et al. [13]
prepared heterogeneous FeIIFeIII-layered double hydroxide (FeIIFeIIILDH) modified carbon
felt by an in situ solvothermal method for ofloxacin removal. Hydroxyl radical mediated
mineralisation of ofloxacin was attributed to the formation of BDD(•OH) via the electro-
chemical process and surface iron oxide catalysis through the FeIIFeIII cycle. These results
support the work of Ganiyu et al. [37], who evaluated FeIIFeIIILDH modified carbon felt
as cathode for sulfamethoxazole degradation. Nsubuga et al. [38] synthesised a Cu–B–Fe
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modified-graphite electrode and trailed the approach for the degradation of two β-blockers
(atenolol and propranolol). As was previously observed, they also concluded that the
bimetallic catalysts possess higher stability than monometallic electrode materials and
additionally benefited from good thermal and recycling stability and conductivity. The use
of magnetic single walled carbon nanotubes (MWCNTs) as a carrier for the electrocatalyst
was reported by Pourzamani et al. [39]. These materials possess a high specific surface area,
notable chemical and mechanical stability and high electrical conductivity. Comparative
analysis between several electrocatalytic degradation technologies demonstrated MWCNTs
to have a high efficiency and enhanced energy-saving than three-dimensional electrode
systems, likely due to the significantly greater surface area of the MWCNTs and the strong
interaction between Fe2O3 and MWCNTs.
6. Application of Electro-Fenton Process for the Removal of Pharmaceutical Compounds
Given the interest in new electro-Fenton processes for the remediation of low level,
persistent, recalcitrant emerging water pollutants, and in particular pharmaceutical com-
pounds, antibiotics, β-blockers and nonsteroidal anti-inflammatory drugs (NSAIDs) have
been prominently featured in published research over last five years, as shown in the
comprehensive summary (Tables 2 and 3). In this section, several investigations have
been discussed based on the type of pharmaceutical compounds. Although the miner-
alisation pathways of these compounds depend on the molecular structure of the target
pollutant and operational conditions, common oxidation steps take place on the degrada-
tion/mineralisation process by electro-Fenton-based processes. Succinctly, hydroxylation
reactions on the side chain occur by the attack of hydroxyl radicals and hydroxylated
cyclic hydrocarbons were obtained by the cleavage of C–S, N=N, N–N, S–N, C–N, C–C and
C=C bonds. For instance, the C=C bond on the tetracycline molecule has been reported
as the most reactive position for the hydroxyl radical attack leading to the production
of the major intermediate [13]. Further hydroxylation, decarboxylation, demethylation,
deamination, desulfonation and dichlorination reactions, as well as ring opening steps lead
to the formation of short-chain carboxylic acids reported as end-products prior to the total
mineralisation up to carbon dioxide, water and inorganic ions.
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TOC: total organic carbon, BDD: boron-doped diamond, CF: carbon felt, GF: graphite felt, MSWCNTs: magnetic single walled carbon nanotubes, AFR: air flow rate, GO: graphene oxide, PTFE: polytetrafluoroethylene.
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0.05 M Na2SO4, pH: 3,
I = 25 mA 97% removal (60 min) [33]
Ibuprofen
(4 mg/L) Fe–NFP Ti–PbO2/GF pH: 6.3, d = 15.77 mA/cm
2 98% removal (38 min) [35]
Naproxen
(4 mg/L) Fe–NFP Ti–PbO2/GF pH: 6.24, d = 18.91 mA/cm





0.05 M Na2SO4, pH: 5.56,
AFR: 1 mL/min,
d = 19.74 mA/cm2
98% removal (83 min) [39]
Ciprofloxacin
(0.1 mM) Fe
2+(0.1 mM)/MnCo2O4 Pt plate/MnCo2O4–CF
0.05 M Na2SO4, pH: 3,
AFR: 10 L/h, I = 300 mA
100% removal (300 min)
75% TOC decay (300 min) [36]
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Sulfamethazine
(10 mg/L) MoS2 (0.02 g/L)/Fe
0 (0.224 g/L) Ti–TiO2–RuO2/CB–CF
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AFR: 50 mL/min,
I = 50 mA
100% removal (10 min)
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AFR: 0.1 L/min,
d = 40 mA/cm2
98.1% removal (120 min)
89% TOC decay (360 min) [20]
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100% removal (90 min)
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0.02 M Na2SO4, pH: 6,
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89.9% removal (100 min)






0.05 M Na2SO4, pH: 3, AFR: 1 L/min,
d = 7.5 mA/cm2
100% removal (40 min)






0.05 M Na2SO4, pH:7,
AFR: 0.75 L/min,
d = 12.5 mA/cm2
100% removal (30 min)
100% TOC decay (480 min) [13]
TOC: total organic carbon, CF: carbon felt, GF: graphite felt, MSWCNTs: magnetic single walled carbon nanotubes, CB–CF: carbon black modified carbon felt, NLDH: nano-layered double hydroxide;
AFR: air flow rate, CNTs: carbon nanotubes, NFP: nickel foam particles.
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6.1. Antibiotics
The widespread overuse of antibiotics, mainly in primary care, and poor removal
efficiency in WWTP results in trace level antibiotics being considered a significant hazard
to both environment and human health. Tetracycline, used to control the urinary tract,
respiratory tract and the intestinal infections has been detected in natural water at concen-
trations up to 1.4 µg/L [27]; likewise, ciprofloxacin, widely used against a range of bacterial
infections has been detected at concentrations ranging from 0.407 nmol/L in Europe to
20,000 nmol/L in Asia [52].
Fluoroquinones including ciprofloxacin, levofloxacin or ofloxacin have been detected
in aquatic ecosystems and drinking water at concentrations around ng/L [36]. Mi et al. [36]
examined the effectiveness of carbon felt modified with MnXCo3-XO4 mesoporous nanopar-
ticles for ciprofloxacin removal. SEM images showed the successful deposition of MnCo2O4
nanoparticles on the carbon felt surface and uniform distribution of the elements within
the nanoparticles. Based on cyclic voltammetry analysis, the authors concluded that higher
intrinsic electron transfer promoted increased redox reaction capacity due to the synergetic
effect between the transition metals in the mesoporous structure. Electron-density distribu-
tion analysis showed Co to be present as an electron-rich species (e.g., cobalt oxides) with
the uniform nature of the total electron density map suggesting an electron transfer from
Co to Mn. Furthermore, the large specific surface area, notable H2O2 yield and excellent
hydroxyl radical production rate promoted high levels of ciprofloxacin removal. Similar
results were obtained by Du et al. [33], who degraded levofloxacin using Fe/Fe3C and
graphitised porous carbon shell systems. A particular benefit of this system is the inherent
magnetic property which permits the post-treatment separation of the particles, recycling
and reuse. From their results, the saturation magnetisation decreased from 70.1 up to
49.5 emu/g after use due to leaching of iron and the deposition of iron oxides on the
particles during pollutant degradation experiments.
Yang et al. [13] also analysed supported catalysis, investigating the performance of
FeIIFeIII-LHD modified carbon felt cathodes for ofloxacin removal at near neutral pH. Com-
plete TOC abatement was attained after a 480 min treatment in a system applying a current
density of 9.37 mA/cm2. Notable removal efficiency was observed at pH 7 as a result of
the surface catalysed process at the solid–liquid interface, preventing the precipitation of
iron hydroxide. The authors calculated the electroactive surface of the modified cathode
and unmodified materials to determine the rate of the electrochemical reactions on the
cathode, using cyclic voltammetry runs in a 10 mM [Fe(CN)6]3-/[Fe(CN)6]4- solution with
the electroactive surface estimated by Randles–Sevcik equation (Equation (31)):
IP = 2.69 × 105 × A × D1/2 × n1/2 × ν1/2 × C (31)
where IP is the maximum peak current (A), n is the number of electrons involved in the
redox reaction (n = 1), A is the area of the electrode (cm2), D is the diffusion coefficient
of the molecule in the solution (7.6 × 10−6 cm2/s), C is the concentration of the standard
molecule in the bulk solution (10−5 mol/mL) and ν is the scan rate (0.01 V/s).
Accordingly, the electroactive surface area was calculated to be 42 cm2 for the raw
carbon felt and 127 cm2 with the FeIIFeIII LDH-modified CF, thus, a three-fold improvement
in surface area resulted in the increased performance of the electrocatalytic reactions on
the cathode. Consequently, the increasing current density impacted on the economic
parameters (MCE and EC) and parallel reactions were observed, such as H2 evolution on
the cathode and O2 formation on the anode. Positive outcomes included negligible iron
leaching demonstrating catalyst stability at circumneutral pH.
Tetracyclines represent another common class of antibiotics, with many studies tar-
geting their removal. The use of iron-based minerals such as pyrite and chalcopyrite was
investigated by Oturan and Brillas groups [17,27] achieving a 100% removal of tetracy-
cline (C22H24N2O8) in less than 20 min. Under similar operational conditions, the use of
chalcopyrite as a catalyst exhibited a higher degree of mineralisation due to the contribu-
tion of copper ions. Given the complexity of the tetracycline molecule, the formation of
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recalcitrant intermediate products results in significant impact on MCE depletion which is
accompanied by an increase in energy consumption per TOC unit. Therefore, the authors
suggested a sequential process based on the chalcopyrite/electro-Fenton process followed
by conventional treatments for practical applications.
Droguett et al. [16] evaluated the potential use of chalcopyrite as a heterogeneous cata-
lyst to degrade cephalexin achieving a 94% removal of the parent compound within 30 min
treatment, however, as can be seen in Table 2, only 44% mineralisation was reached after
300 min due to the emergence of recalcitrant intermediates, such as aromatic compounds
and short-chain carboxylic acids, the latter leading to the formation of stable organo-iron
complexes, which cannot be degraded by hydroxyl radicals. Ecotoxicological effects of
these by-products of electro-Fenton treatment are often evaluated by classical toxicity
studies including Vibrio fischeri (Microtox®test), Daphnia magna or Escherichia coli as model
organisms used to assess the general toxicity of the effluent produced from treatment.
Sulphonamide antibiotics, such as sulfamethazine, possess antibacterial activity being
widely used for human and veterinary clinical purposes [53,54] and as a consequence
has been detected in effluents from the sewage treatment plant and surface water at
concentrations ranging from 20 to 1000 ng/L [55]. Many researchers have studied this
group of antibiotics over the last five years using a heterogeneous electro-Fenton process
(Table 2) [14,33,40]. Tian et al. [14] used commercial MoS2 as a co-catalyst to develop an
efficient MoS2/Fe0 co-catalytic electro-Fenton process. Almost complete sulfamethazine
degradation was achieved after 20 min by Fe0-electro-Fenton process whereas only 10 min
were necessary to achieve the same removal percentage when MoS2 was introduced as a co-
catalyst. These results concur with the data for homogeneous electro-Fenton process, with a
higher sulfamethazine removal rate evident in the presence of the co-catalyst. The effect was
attributed to the acceleration of the Fe3+/Fe2+ reactions (Equation (14)) with an associated
increase in the generation of hydroxyl radicals (Equation (17)) experimentally demonstrated.
Similar sulfamethazine degradation studies were also reported by Barhoumi et al. [40] and
Du et al. [33].
The degradation of sulfamethizole was undertaken by Puga et al. [32], who used
electro-Fenton process in ultrapure water and real treated wastewater spiked with the pol-
lutant (final concentration around 25 mg/L) under a continuous flow-system. The authors
assumed a first-order kinetic model for mineralisation data reporting kinetic rate constants
around 0.27 and 0.15 1/h for ultrapure and real water, respectively, demonstrating the
challenge of working with real effluent. Campos et al. [29] also observed this effect, re-
porting the influence of feed water composition on radical scavenging reactions coupled
with mass transfer limitations due to the presence of organic matter. Under optimal con-
ditions, nafcillin was completely removed from the slaughterhouse effluent after 15 min
treatment, demonstrating efficacy in a very challenging wastewater matrix. A range of
other works report similar behaviour [49,56] within limited TOC reduction observed in
effluent-based experiments.
β-lactam antibiotics, including penicillin, are a group of compounds commonly used
to treat a wide range of bacterial infections. Amoxicillin, a well-known broad-spectrum
β-lactam is non-biodegradable and detected in groundwater, surface waters, hospital
effluents and industrial wastewater streams at concentrations ranging from sub-ng/L up
to 87.5 g/L [57]. Their toxic and recalcitrant character hinders removal by conventional
biological treatments and thus, the use of AOPs including Fenton-based processes have
been investigated for amoxicillin degradation [58–60]. Kalantary et al. [42] studied the
performance of a heterogeneous electro-Fenton process using nano-Fe3O4 modified-carbon
felt cathodes which increased the H2O2 yield 5.2-fold without aeration, demonstrating
promise for the application of the electro-Fenton process at low oxygen levels. Optimisation
of the process was carried out to ensure the minimum applied current and as such deliver
an economic and energy favourable process, with the authors reporting a tenfold decrease
in terms of energetic consumption (Equation (23)) within a minimal impact on process
effectiveness (9% decrease from optimal efficiency).
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Chloramphenicol, a broad-spectrum antibiotic used in veterinary medicine, and al-
though banned in the European Union and many other countries due to its harmful effects
detected in humans, has been detected in food products arriving from Asia [61]. Several
authors have reported the applicability of AOPs to degrade chloramphenicol by hydroxyl
and sulphate radical-based mechanisms [62,63]. Görmez et al. [45] reported the potential
of GO-Fe3O4 as an electro-Fenton catalyst, noting around 80% mineralisation following
300 min treatment under optimal conditions with 16% higher TOC removal when com-
pared to the homogeneous electro-Fenton process. The authors suggested relatively higher
activation energy was required for the initiation step of the degradation reaction due
to the slow decay of the parent compound. Adsorption studies confirmed that the GO–
Fe2O3 catalyst contributed directly to the Fenton reaction rather than simply increasing
pollutant adsorption.
Nitroimidazole antibiotics, including metronidazole, have been widely used to treat
infections caused by anaerobic and protozoan bacteria and have been detected in hospital
effluents at concentrations in the range of 1.8–9.4 µg/L [64]. Their low biodegradability,
high solubility in water and complex molecular structure hinder their removal by conven-
tional systems [65]. Thus, Rahmatinia and Rahmatinia [41] studied metronidazole removal
using nano-Fe3O4 as a heterogeneous catalyst reaching 92.2% removal under optimal
conditions (70 mg/L initial concentration, pH 3, 200 mA applied current intensity and
3.2 kWh/m3). Similar results have been reported by Görmez et al. [45] with data showing
near total degradation after 15 min treatment.
6.2. β-Blockers
Beta adrenergic antagonists (β-blockers) have been widely prescribed to treat cardiac
arrhythmias, hypertension and angina, and are commonly detected illegally during an-
tidoping controls [66,67] with transport to the environment reported via effluents from
pharmaceuticals plants, hospitals, retirement homes and private households [68].
β-blockers are considered a significant threat to the aquatic organisms due to their
high persistence and bioaccumulation in water bodies [69,70]. Nsubuga et al. [46] devel-
oped a promising approach for the total elimination of parent propranolol and acebutolol,
and their metabolites, using Fe–C nanocomposites synthesised from rice husk. The use of a
droplet flow-assisted heterogenous electro-Fenton reactor ensured synergetic mechanisms
of degradation enhancement based on an increased surface area from the droplet chemistry
and micro-electrolysis arising from the Fe–C nanocomposite [46]. pH adjustment was not
required given the nature of the biogenic iron composites which self-regulate acidity as
observed in pyrite and chalcopyrite systems. The authors suggested an electrochemical
degradation pathway based on the side chain cleavage to form an amino-diol and hydroxy-
lation of the aromatic ring. Subsequently, Nsubuga et al. [38] analysed copper–boron–ferrite
(Cu–B–Fe)-supported graphite electrodes using droplet flow-assisted heterogenous electro-
Fenton process for atenolol and propranolol in hospital effluent. SEM images showed a
high dispersion of the Cu, B and Fe on the functionalised cathodic surface. Furthermore,
near rectangular shaped cyclic voltammograms of these modified electrodes confirm their
high potential to increase electron transfer on the electrode surfaces. Consequently, these
electrodes demonstrated excellent activity for in situ H2O2 electrogeneration, hydroxyl
radical production and catalyst regeneration.
6.3. NSAIDs
NSAIDs are frequently prescribed to treat pain and inflammation associated with
arthritis, including acetaminophen (paracetamol), ibuprofen, naproxen and diclofenac;
however, few publications have evaluated the production and fate of oxidation by-products
and their ecotoxicological effects [71]. Given the routine detection in the aquatic environ-
ment [72], the EU Water Framework Directive lists ibuprofen within the first Watch List
given regular detection in freshwater and wastewater treatment plant effluents at con-
centrations over 30 µg/L [73]. Liu et al. [49] reported the use of activated carbon fibre
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supported ferric citrate as a modified cathode, achieving 96% ibuprofen degradation at
5 mA/cm2 current density after 120 min treatment. High MCE, around 46%, was obtained
in comparison with other heterogeneous electro-Fenton processes [31,40]. In addition, this
modified cathode is also suitable for use at circumneutral pH similar to Fe2O3/kaolin
catalysts [31].
Diclofenac is a popular choice of model compound within the scientific commu-
nity [39,43,44] and has been detected in surface water and groundwater at concentration
levels ranging from 0.8 ng/L to 4.4 µg/L [74–76]. Its high solubility at neutral-alkaline
conditions and low solubility at pH ≤ pKa (around 4.91) considerably hinder its removal
by conventional treatments [77,78]. Rosales et al. [43] have proposed an innovative ap-
proach at near neutral pH by using iron chitosan–epichlorohydrin spheres. Previously,
Pourzamani et al. [39] reported good removal efficiency using 3D electro-Fenton process
based upon multi-walled carbon nanotubes (MWCNTs)–Fe3O4 as the electrode. More than
70% degradation was achieved following 120 min, a two-fold increase over heterogeneous
electro-Fenton process without cathodic-modification demonstrating the effectiveness of
the microelectrodes to increase both indirect and direct oxidation. In addition, less H2O2
accumulation was detected in the bulk solution as a result of rapid decomposition to
hydroxyl radicals [79]. Similar enhancement was reported by Sadeghi et al. [44] using
Fe–MWCNTs as the heterogeneous catalyst.
7. Photoelectro-Fenton Process
The effectiveness of the heterogenous electro-Fenton process may be enhanced through
combination with other technologies. Hybrid processes integrated into systems, sequential
alternative and successive treatments have been proposed with many examples reporting
total pollutant removal from wastewater (summarised in Table 4). Photoelectro-Fenton
(PEF) process represents an ‘upgrade’ to electro-Fenton via the simultaneous exposure of
the solution to UV and/or visible radiation [80] (Figure 3).
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increase in removal vs. the control experiments. UV photons have been shown to play a 
key role enhancing charge transfer and promoting Fe (III)/ Fe (II) cycling. Studies in urban 
wastewater spiked with a range of emerging pollutants, bezafibrate, bisphenol A, fluoxe-
tine and naproxen, and at neutral pH showed good removal efficiencies with 93, 85 and 
78% removal reported for naproxen, fluoxetine and bisphenol A, respectively, after 90 min 
treatment. The authors concluded that the presence of organic matter, the high turbidity 
and the higher initial pH all play a role to reduce bezafibrate treatment. 
Thiam et al. [81] analysed thiamphenicol degradation using photoelectro-Fenton pro-
cess driven with UVA light and pyrite particles as the catalyst source. The regulatory role 
pyrite plays regarding solution acidification (according to the Equations 26–28) was de-
scribed to be significant, resulting in enhanced hydroxyl radicals generated via the photo-
Fenton reaction. Under optimal conditions, more than 85% TOC decay was achieved after 
360 min treatment, noted to be around a three-fold increase in comparison to the electro-
Fenton process. 
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parameters driving the electro-Fenton process. Although progress has been made with 
nano-engineered catalysts, high operating costs related to energy consumption, relatively 
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with renewable energy generation sources such as photovoltaic panels, which can be eas-
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turbidity and the higher initial pH all play a role to reduce bezafibrate treatment.
Thia et al. [81] analysed thiamphenicol degradation using photoelectro-Fenton
process driven with UVA light and pyrite particles as the catalyst source. The regulatory
role pyrite plays regarding solution acidification (according to the Equations (26)–(28))
was described to be significant, resulting in enhanced hydroxyl radicals generated via the
photo-Fenton reaction. Under optimal conditions, more than 85% TOC decay was achieved
after 360 min treatment, noted to be around a three-fold increase in comparison to the
electro-Fenton process.
8. Conclusions and Future Perspectives
This review describes the present trends in the use of heterogenous catalysts for the
removal of pharmaceuticals from aquatic environments, discussing the critical role of the
parameters driving the electro-Fenton process. Although progress has been made with
nano-engineered catalysts, high operating costs related to energy consumption, relatively
slow degradation processes, and issues with reactor scale-up and catalyst re-use remain
major challenges for this emerging field of research. Future studies should be focused
on minimising energy consumption, through more efficient electrochemistry, or coupling
with renewable energy generation sources such as photovoltaic panels, which can be easily
scaled for industrial applications. The identification of efficient process parameters to
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deliver treated waters with high parent compound degradation does not always ensure
effluent safety, however, mineralisation is not always required—careful attention should
be paid to reducing the toxicity levels of treated water, and/or enhancing bio-availability
via pre-treatment before wastewater treatment through biological process.
To date, academic research has focused on the initial developments of novel innovative
wastewater treatment technologies for the removal of pharmaceuticals from simulated wa-
ter under batch conditions. However, there is a need to assess efficacy in real water matrices
where the presence of natural organic matter (humic and fulvic acids) will undoubtedly
scavenge radical species reducing the effective degradation rate. The implementation of
heterogeneous-based Fenton process as continuous flow systems is required to ensure
potential for scale-up to real water treatment applications.
Significant efforts have been devoted to producing novel solid iron catalysts or iron-
functionalised cathodic materials, but more work is needed to evaluate these materials at
circumneutral pH in order to ensure higher stability whilst maintaining ability to catalyse
Fenton’s reaction forming hydroxyl radicals. One area of significant promise is the integra-
tion of the electro-Fenton process with conventional technologies, and/or Fenton-based
processes and indeed other AOP’s, with significant improvements in mineralisation percent-
ages observed. This topic remains a vibrant area for research and through the identification
of niche applications could quickly transition to pilots and commercial exploitation.
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